Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance. Danish ...

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...

Eli Lilly is offering vials of its obesity drug Zepbound to patients at a discount — but only if they skip their insurance.

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for diabetes and obesity for patients who have to pay for the drug themselves. It said it will ...

Eli Lilly's drive to provide as many treatment options as possible for its weight-loss drug Zepbound has continued with the launch of new high-dose vials sold at a $150 discount to its auto ...

Telehealth company Ro will offer single-dose vials of Eli Lilly's obesity therapy Zepbound in an expansion of the ways patients with a prescription can access the drug. The agreement means Ro has ...

2-Year U.S. Treasury Note Continuous Contract $103.453-0.031-0.03% 5-Year U.S. Treasury Note Continuous Contract $107.859-0.078-0.07% 10-Year U.S. Treasury Note Continuous Contract $111.031-0.063 ...

Out of the past: March 3Reflecting on March 4th through the years: In 2000, Cape Girardeau mourned the loss of Mildred "Millie" Limbaugh. In 1975, local farmers rallied for better prices. In 1950 ...

Eli Lilly announced Tuesday that it is selling higher-dose vials of Zepbound at lower prices in its direct-to-consumer program. The program offers self-administered vials for people whose insurance ...

Manufactured by Eli Lilly and Company, both Mounjaro and Zepbound contain the active ingredient tirzepatide. Tirzepatide is similar to semaglutide, which is used in medications like Ozempic, Rybelsus, ...

Annalee Armstrong is an award-winning biopharma journalist covering the business of drug development. She began her career at small newspapers across Western Canada. During the assignment of a ...